Biocon trades higher on the bourses

23 Jun 2016 Evaluate

Biocon is currently trading at Rs. 718.35, up by 3.15 points or 0.44% from its previous closing of Rs. 715.20 on the BSE.

The scrip opened at Rs. 720.50 and has touched a high and low of Rs. 725.45 and Rs. 711.00 respectively. So far 21400 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 761.00 on 22-Jun-2016 and a 52 week low of Rs. 396.50 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 761.00 and Rs. 710.75 respectively. The current market cap of the company is Rs. 14388.00 crore.

The promoters holding in the company stood at 60.72%, while Institutions and Non-Institutions held 19.35  and 19.93  respectively.

Drug Controller General of India (DCGI) has given nod to Biocon and its partner Quark Pharmaceuticals to proceed with clinical trials on human subjects for a new drug candidate, 'QPI-1007' aimed for ocular neuroprotection. The company and Quark Pharmaceuticals have also randomized the first patient in India in the global Phase II/III study of the new drug candidate. Randomisation is the allocation of subjects to treatment groups to prevent selection and accidental bias.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

393.90 3.50 (0.90%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×